MD872F1 - Pharmaceutical effervescent composition and preparation on the basis of it, method for preparation preparing - Google Patents

Pharmaceutical effervescent composition and preparation on the basis of it, method for preparation preparing

Info

Publication number
MD872F1
MD872F1 MD95-0026A MD950026A MD872F1 MD 872 F1 MD872 F1 MD 872F1 MD 950026 A MD950026 A MD 950026A MD 872 F1 MD872 F1 MD 872F1
Authority
MD
Moldova
Prior art keywords
preparation
pharmaceutically acceptable
ibuprofen
basis
composition
Prior art date
Application number
MD95-0026A
Other languages
Romanian (ro)
Other versions
MD872G2 (en
Inventor
Nicole Francoise Bru-Magneiz
Jean-Francois Simon Cordoliani
Gerard Jacques Thauvin
Jehan-Yves Pierre Drouin
Original Assignee
Upsa Francaise Societe Anonyme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9436398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MD872(F1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upsa Francaise Societe Anonyme filed Critical Upsa Francaise Societe Anonyme
Publication of MD872F1 publication Critical patent/MD872F1/en
Publication of MD872G2 publication Critical patent/MD872G2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

The present invention relates to a novel pharmaceutical composition for the preparation of effervescent powders or tablets incorporating ibuprofen or one of its pharmaceutically acceptable salts as the active ingredient. This composition comprises: an effective amount of ibuprofen or one of its pharmaceutically acceptable salts; a pharmaceutically acceptable effervescent system comprising at least one alkaline carbonate and at least one organic acid, preferably in a sufficient amount to give a pH below about 8; and at least one pharmaceutically acceptable antioxidant in a sufficient amount to stabilize the ibuprofen. This composition has a remarkable stability both in powder form and in tablet form.
MD95-0026A 1992-12-09 1994-12-22 Pharmaceutical effrvescent composition and preparation on the basis of it, method for preparation preparing MD872G2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9214851A FR2698788B1 (en) 1992-12-09 1992-12-09 Effervescent pharmaceutical composition containing ibuprofen and process for its preparation.

Publications (2)

Publication Number Publication Date
MD872F1 true MD872F1 (en) 1997-11-30
MD872G2 MD872G2 (en) 1998-08-31

Family

ID=9436398

Family Applications (1)

Application Number Title Priority Date Filing Date
MD95-0026A MD872G2 (en) 1992-12-09 1994-12-22 Pharmaceutical effrvescent composition and preparation on the basis of it, method for preparation preparing

Country Status (26)

Country Link
US (2) US5480652A (en)
EP (1) EP0673245B1 (en)
JP (1) JP3579421B2 (en)
KR (1) KR950702414A (en)
AT (1) ATE158504T1 (en)
AU (1) AU679200B2 (en)
CA (1) CA2150945C (en)
CZ (1) CZ289304B6 (en)
DE (1) DE69314186T2 (en)
DK (1) DK0673245T3 (en)
EE (1) EE03089B1 (en)
ES (1) ES2110212T3 (en)
FI (1) FI111517B (en)
FR (1) FR2698788B1 (en)
GE (1) GEP19991686B (en)
GR (1) GR3025634T3 (en)
HU (1) HU220632B1 (en)
LV (1) LV11984B (en)
MD (1) MD872G2 (en)
NZ (1) NZ258596A (en)
RU (1) RU2134577C1 (en)
SK (1) SK281775B6 (en)
TJ (1) TJ253B (en)
TW (1) TW280774B (en)
UA (1) UA27058C2 (en)
WO (1) WO1994013279A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19502789A1 (en) * 1995-01-28 1996-08-01 Dirk Krischenowski Medicament contg. analgesic, antacid, and/or vitamin etc.
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
DE19606151C2 (en) * 1996-02-20 1999-05-12 Losan Pharma Gmbh Effervescent ibuprofen preparation and process for making the same
US6534016B1 (en) 1997-04-30 2003-03-18 Richmond Cohen Additive preparation and method of use thereof
US6225123B1 (en) 1997-04-30 2001-05-01 Becton Dickinson And Company Additive preparation and method of use thereof
GB9721397D0 (en) * 1997-10-09 1997-12-10 Verdugt Bv Anticaking agents
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
DE19814257A1 (en) * 1998-03-31 1999-10-07 Asta Medica Ag effervescent formulations
DE19814256A1 (en) * 1998-03-31 1999-10-07 Asta Medica Ag Solid, fast-breaking cetirizine formulations
IT1301966B1 (en) 1998-07-30 2000-07-20 Zambon Spa PHARMACEUTICAL COMPOSITIONS WITH ANALGESIC ACTIVITY
DE19962251A1 (en) * 1999-12-22 2001-09-06 Hermes Fabrik Pharm Praeparate Lozenge with thermally neutral dissolution properties containing active substance with exothermic dissolution behavior and compensatory adjuvant with endothermic dissolution behavior
AU2001260083A1 (en) 2000-05-26 2001-12-03 Dr. Reddy's Research Foundation New pharmaceutical composition and the process for its preparation
WO2001091751A1 (en) * 2000-05-30 2001-12-06 Novo Nordisk A/S New pharmaceutical composition and the process for its preparation
AR029538A1 (en) * 2000-07-06 2003-07-02 Wyeth Corp PHARMACEUTICAL COMPOSITIONS OF ESTROGEN AGENTS
US7488496B2 (en) * 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
EP1490024B1 (en) 2002-03-06 2012-01-18 EffRx Pharmaceuticals SA Effervescent compositions comprising alendronate
DE102006029233A1 (en) * 2006-06-26 2007-12-27 Liedtke, Rainer K., Dr. Formulations to improve the tolerability of non-steroidal anti-inflammatory drugs
EP1902708A1 (en) * 2006-09-25 2008-03-26 Losan Pharma GmbH Drug comprising stabilized pharmaceutical solid compositions and processes for their preparation
US8445545B2 (en) * 2008-05-07 2013-05-21 Nicholas DeSica Pharmaceutical composition, method of preparation and methods of treating aches/pains
US10221218B2 (en) 2011-05-10 2019-03-05 The Regents Of The University Of California Adenovirus isolated from titi monkeys
WO2012154994A2 (en) 2011-05-10 2012-11-15 The Regents Of The University Of Californa A novel adenovirus isolated from titi monkeys
CA2863613C (en) 2012-02-01 2020-10-27 Intercontinental Great Brands Llc Low calorie drink tablet
JP5877778B2 (en) * 2012-05-28 2016-03-08 株式会社ホットアルバム炭酸泉タブレット Tablet manufacturing method and tablet
RU2519099C1 (en) * 2012-11-08 2014-06-10 Федеральное государственное бюджетное учреждение науки Ордена Трудового Красного Знамени Институт нефтехимического синтеза им. А.В. Топчиева Российской академии наук (ИНХС РАН) Pharmaceutical composition
FR3060391A1 (en) * 2016-12-20 2018-06-22 Promindus Sarl PHARMACEUTICAL COMPOSITION ANTI-PAIN

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
CH677606A5 (en) * 1988-07-12 1991-06-14 Aesculapius Pharma Sa
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles

Also Published As

Publication number Publication date
JPH08504427A (en) 1996-05-14
CZ141995A3 (en) 1995-10-18
GR3025634T3 (en) 1998-03-31
FI111517B (en) 2003-08-15
HU9501671D0 (en) 1995-08-28
SK281775B6 (en) 2001-07-10
UA27058C2 (en) 2000-02-28
ES2110212T3 (en) 1998-02-01
EE03089B1 (en) 1998-06-15
RU2134577C1 (en) 1999-08-20
US5567437A (en) 1996-10-22
TJ253B (en) 2000-05-12
TW280774B (en) 1996-07-11
EP0673245B1 (en) 1997-09-24
CZ289304B6 (en) 2001-12-12
KR950702414A (en) 1995-07-29
US5480652A (en) 1996-01-02
AU679200B2 (en) 1997-06-26
ATE158504T1 (en) 1997-10-15
FI945452A0 (en) 1994-11-21
FR2698788B1 (en) 1995-03-03
AU5653694A (en) 1994-07-04
NZ258596A (en) 1997-01-29
WO1994013279A1 (en) 1994-06-23
HUT73249A (en) 1996-07-29
JP3579421B2 (en) 2004-10-20
CA2150945C (en) 2006-11-28
DE69314186T2 (en) 1998-02-12
FR2698788A1 (en) 1994-06-10
DK0673245T3 (en) 1998-04-27
LV11984B (en) 1998-05-20
CA2150945A1 (en) 1994-06-23
HU220632B1 (en) 2002-03-28
DE69314186D1 (en) 1997-10-30
SK72895A3 (en) 1995-11-08
GEP19991686B (en) 1999-08-05
MD872G2 (en) 1998-08-31
LV11984A (en) 1998-03-20
EP0673245A1 (en) 1995-09-27
FI945452A (en) 1995-06-07

Similar Documents

Publication Publication Date Title
MD872F1 (en) Pharmaceutical effervescent composition and preparation on the basis of it, method for preparation preparing
IL74707A (en) Anti-viral compositions comprising pyridazinamines,certain such novel compounds and their preparation
TW376319B (en) Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
HUT64065A (en) Process for producing quinolone- and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions comprising same as active ingredient
HUT60466A (en) Process for producing amino acid derivatives and pharmaceutical compositions comprising such active ingredient
CA2106423A1 (en) Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
CA2158630A1 (en) Dosage forms containing thioctic acid or solid salts of thioctic acid with improved release and bioavailability
TW355683B (en) Composition containing micronized nebivolol
WO1997012583A3 (en) Stable compositions containing n-propargyl-1-aminoindan
CA2354057A1 (en) Sustained release tablet containing hydrocolloid and cellulose ether
UA66812C2 (en) Drug formulation with controlled release of active ingredient
CA2120048A1 (en) Pharmaceutical composition having analgesic activity
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
UA40636C2 (en) pharmaceutical composition containing, as the active ingredient, an association of acetylsalicylic acid and metoclopramide, pharmaceutical medication in the form of powder and method for its preparation
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
NZ331083A (en) Pharmaceutical preparations of cilansetron stabilized against racemization
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
HUT54166A (en) Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient
MXPA01004457A (en) Novel pyrimidine derivatives and processes for the preparation thereof.
HUT61740A (en) Process for producing 2-piperidinyl-pyrimidine-4-carboxamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT53121A (en) Process for producing amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
IE43848L (en) Pharmaceutical compositions
MY102368A (en) Solid sustained-release composition
MX9705592A (en) Liposomes containing a corticosteroid.

Legal Events

Date Code Title Description
FG3A Granted patent for invention
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20141222